BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Janelle V, Delisle JS. T-Cell Dysfunction as a Limitation of Adoptive Immunotherapy: Current Concepts and Mitigation Strategies. Cancers (Basel) 2021;13:598. [PMID: 33546277 DOI: 10.3390/cancers13040598] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Wang H, Wang Z, Liu S. Lipid Nanoparticles for mRNA Delivery to Enhance Cancer Immunotherapy. Molecules 2022;27:5607. [DOI: 10.3390/molecules27175607] [Reference Citation Analysis]
2 Sailer N, Fetzer I, Salvermoser M, Braun M, Brechtefeld D, Krendl C, Geiger C, Mutze K, Noessner E, Schendel DJ, Bürdek M, Wilde S, Sommermeyer D. T-Cells Expressing a Highly Potent PRAME-Specific T-Cell Receptor in Combination with a Chimeric PD1-41BB Co-Stimulatory Receptor Show a Favorable Preclinical Safety Profile and Strong Anti-Tumor Reactivity. Cancers 2022;14:1998. [DOI: 10.3390/cancers14081998] [Reference Citation Analysis]
3 Janelle V, Neault M, Lebel MÈ, De Sousa DM, Boulet S, Durrieu L, Carli C, Muzac C, Lemieux S, Labrecque N, Melichar HJ, Mallette FA, Delisle JS. p16INK4a Regulates Cellular Senescence in PD-1-Expressing Human T Cells. Front Immunol 2021;12:698565. [PMID: 34434190 DOI: 10.3389/fimmu.2021.698565] [Cited by in F6Publishing: 2] [Reference Citation Analysis]